GEOGRAPHIC VARIATIONS IN KIDNEY FUNCTION TESTING AMONG PATIENTS WITH TYPE 2 DIABETES (T2D)

被引：0
|
作者：
Feng, Xue [1 ,2 ]
Betts, Keith A. [3 ]
Song, Jinlin [3 ]
Wu, Aozhou [3 ]
Elliott, Jay [2 ]
Warnock, Neil [2 ]
Farej, Ryan [2 ]
Singh, Rakesh [2 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
[2] Bayer Healthcare Pharmaceut Inc, Whippany, NJ 07981 USA
[3] Anal Grp Inc, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2021年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
84
引用
收藏
页码：592 / 593
页数：2
相关论文
共 50 条
  • [1] Geographic Variations in Healthcare Resource Utilization (HRU) and Costs and Their Associations with Albuminuria Testing in Patients with CKD and Type 2 Diabetes (T2D)
    Singh, Rakesh
    Betts, Keith A.
    Song, Jinlin
    Wang, Yao
    Elliott, Jay
    Warnock, Neil
    Farej, Ryan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 272 - 272
  • [2] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [3] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A397 - A397
  • [4] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)
  • [5] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    DIABETES, 2021, 70
  • [6] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [7] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306
  • [8] Effort Reward Imbalance (ERI) among Workers with Type 2 Diabetes (T2D)
    Olesen, Kasper
    Cleal, Bryan
    Willaing, Ingrid
    DIABETES, 2016, 65 : A219 - A219
  • [9] Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods
    Rainer, Raphael
    Elsayed, Hesham
    Aberer, Felix
    Beck, Peter
    Pieber, Thomas R.
    Donsa, Klaus
    Plank, Johannes
    Mader, Julia K.
    DIABETES, 2018, 67
  • [10] Real-World Effectiveness among Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide (TZP)
    Mody, Reema
    Desai, Karishma
    Teng, Chia-Chen
    Reznor, Gally
    Stockbower, Grace
    Grabner, Michael
    Benneyworth, Brian D.
    DIABETES, 2024, 73
12345